Pharmacovigilance – Products

Presentation included additional results arising from recent analyses relating to muscle strength at 24 hours and concentration-response relationships.

MJR PharmJet reckons improved efficacy and reduced side-effects of approved and new drugs.

Trial is designed to evaluate the safety and efficacy of RPL554 in patients with mild to moderate forms of COPD.

Company has raised $100 million total since inception.

Animal study demonstrates midkine treatment reduces heart muscle death by 27% following heart attack.

Cambridge Healthtech Associates and Metanomics Health GmbH announce a collaborative technology evaluation.

Project aims to identify personalized treatment for each individual while minimizing the healthcare costs and side effects experienced by subjects.

Bosch expands its portfolio in syringe processing and pure water generation.

Services offer an extensive array of tests designed to give an early evaluation of safety of drugs thought to have development potential.

Atlas CDS™ provides chromatographers with a client/server chromatography-based software solution available for controlling multi-vendor instruments.